StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / kinomica.com

Kinomica

Kinomica (kinomica.com): 3 changes recorded in its website history since July 2019. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. HeadlineBetween and
    BeforePhosphoproteomics for Precision Medicine
    AfterOur goal is to help clinicians select the right therapy, for the right patient, at the right time

    Observed on the company’s website; business claims are not independently verified.

  2. HiringBetween and

    Added a careers page.

    Observed on the company’s website; business claims are not independently verified.

  3. ComplianceBetween and

    Now states FDA-APPROVED compliance on its homepage.

    Observed on the company’s website; business claims are not independently verified.

First recorded website

Observed 25 July 2019

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Kinomica Limited

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. May 2024 – November 2026 · 5 captures · latest observed messagingOur goal is to help clinicians select the right therapy, for the right patient, at the right time

    This wording observed 6 November 2026.

    Inspect 5 captures in this group
    • 22 May 2024 · Our goal is to help clinicians select the right therapy, for the right patient, at the right time archived page
    • 20 July 2024 · Our goal is to help clinicians select the right therapy, for the right patient, at the right time archived page
    • 15 July 2025 · Our goal is to help clinicians select the right therapy, for the right patient, at the right time archived page
    • 12 March 2026 · Our goal is to help clinicians select the right therapy, for the right patient, at the right time archived page
    • 6 November 2026 · Our goal is to help clinicians select the right therapy, for the right patient, at the right time current websiteHistorical capture not publicly available
  2. August 2021 – February 2023 · 3 capturesPhosphoproteomics for Precision Medicine

    Kinomica developed KScan®, a phosphoproteomic diagnostic platform to help clinicians prescribe the right drug.

    This wording observed 14 February 2023.

    Inspect 3 captures in this group
    • 4 August 2021 · Revolutionary Technologies for Precision Medicine archived page
    • 19 January 2022 · Revolutionary Technologies for Precision Medicine archived page
    • 14 February 2023 · Phosphoproteomics for Precision Medicine archived page
  3. Seen July 2019 · 1 captureKinomica Limited

    This wording observed 25 July 2019.

Summary of the record · AI-written

Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.

Kinomica updates homepage messaging and notes FDA-approved compliance

Kinomica has highlighted FDA-approved compliance, added a careers page, and shifted its homepage headline wording toward clinician-focused therapy selection.

  • Between July 2019 and January 2021, Kinomica’s homepage began to state FDA-APPROVED compliance. [1]
  • Between January 2021 and August 2021, Kinomica added a careers page to its website. [2]
  • Between February 2023 and May 2024, Kinomica changed its homepage headline from “Phosphoproteomics for Precision Medicine” to “Our goal is to help clinicians select the right therapy, for the right patient, at the right time”. [3]
  • Reading: The updated headline between February 2023 and May 2024 suggests a stronger emphasis on supporting clinicians directly in therapy selection, compared with its previous phosphoproteomics-focused wording. [3]

Cite this record

StartupHistory, “Kinomica” company record, https://startuphistory.org/c/kinomica.com

Machine-readable: /c/kinomica.com.json. How changes are found: method.